Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status.
Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis.
Pooling real-world multiple sclerosis patient data on a European level: a true story of success.
Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis.
Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis.
Self-tolerance in multiple sclerosis.
Neuropsychiatric symptoms as a manifestation of multiple sclerosis after 2-year follow-up period.
Vitamin D status and ill health: a systematic review.
Use of Neurofeedback to Enhance Response to Hypnotic Analgesia in Individuals With Multiple Sclerosis.
[Therapeutic effect of encapsulated into the nanocontainers MBP immunodominant peptides on EAE development in DA rats].
Superficial spreading malignant melanoma in a patient on fingolimod therapy for multiple sclerosis.
Multiple Sclerosis Questionnaire for Job Difficulties (MSQ-Job): definition of the cut-off score.
Fingolimod Phosphate Attenuates Oligomeric Amyloid β-Induced Neurotoxicity via Increased Brain-Derived Neurotrophic Factor Expression in Neurons.
Miscellaneous indications for extracorporeal photochemotherapy (ECP).
Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders.
Expert recommendations to personalization of medical approaches in treatment of Multiple Sclerosis: an overview of family planning and pregnancy.
A case with neuromyelitis optica mimicking Susac's syndrome.
Towards a Classification Approach using Meta-Biclustering: Impact of Discretization in the Analysis of Expression Time Series.
Surveillance and medical therapy following endovascular treatment of chronic cerebrospinal venous insufficiency.
Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma.
The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up.
A Mushroom Extract Piwep from Phellinus igniarius Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Immune Cell Infiltration in the Spinal Cord.
A bird's-eye view of T cells during natalizumab therapy.
Atomic structures of amyloid cross-beta spines reveal varied steric zippers.
Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.
Pages
« first
‹ previous
…
202
203
204
205
206
207
208
209
210
…
next ›
last »